6C4C.Z

ICD-11 MMS 2026-01

Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified

Exclusions from above levels

  • QE11.6 – Hazardous use of MDMA or related drugs
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA
  • 6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA
  • 6C4C.2 – MDMA or related drug dependence, including MDA
  • 6C4C.3 – MDMA or related drug intoxication, including MDA
  • 6C4C.4 – MDMA or related drug withdrawal, including MDA
  • 6C4C.5 – MDMA or related drug-induced delirium, including MDA
  • 6C4C.6 – MDMA or related drug-induced psychotic disorder, including MDA
  • 6C4C.7 – Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
  • 6C4C.Y – Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]

Foundation entity

Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] – http://id.who.int/icd/entity/1218193465

Allowed postcoordination axes

Part of: 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders